Cannabinoid receptor systems: therapeutic targets for tumour intervention. (Q35593944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Cannabinoid receptor systems: therapeutic targets for tumour intervention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

John Howl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

749-758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Cannabimimetic fatty acid derivatives in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Effects of delta-9-tetrahydrocannabinol on human immune function and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Cannabinoids and cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Acute neuronal injury, excitotoxicity, and the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Cannabinoids and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Endocannabinoids in the immune system and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Cannabinoid receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Anandamide amidohydrolase (fatty acid amide hydrolase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Malignant glioma: genetics and biology of a grave matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Rap1 mediates sustained MAP kinase activation induced by nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Physiology and pathophysiology of sphingolipid metabolism and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Ceramide: a new second messenger of cannabinoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Chemical characterization of a family of brain lipids that induce sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Anandamide may mediate sleep induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Possible endocannabinoid control of colorectal cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

Interactions between synthetic vanilloids and the endogenous cannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.6.749

21 January 2018

Identifiers

DOI

10.1517/14728222.7.6.749

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14640910%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference